Bookmark and Share

$YGYI University of Pennsylvania to Study CBD Use in Dogs

Every decade or two, there are medical discoveries made that thoroughly shake up the entire pharmaceutical industry. Drugs such as penicillin, insulin, and thorazin not only changed the scope of how severe medical conditions could be treated, but they were instrumental in helping thousands, if not millions of people, live more comfortable and healthy lives.

CBD is, without a doubt, this decade’s superstar. More and more people have started to take notice as testimonials and tons of anecdotal evidence about cannabidiol’s effectiveness pile up. CBD works against pain, inflammation, anxiety, and a host of other conditions quite well. So well, in fact, that people have begun thinking about how CBD can be applied more radically; there’s a new study that will…

Read more »

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Wednesday, October 16th, 2019 Uncategorized